Easterly Investment Partners LLC Sage Therapeutics, Inc. Transaction History

Easterly Investment Partners LLC

$1.22 Billion
Q3 2024

A detailed history of Easterly Investment Partners LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Easterly Investment Partners LLC holds 45,102 shares of SAGE stock, worth $259,787. This represents 0.03% of its overall portfolio holdings.

Number of Shares

45,102

Previous 136,602 66.98%

Holding current value

$259,787

Previous $1.48 Million 78.08%

% of portfolio

0.03%

Previous 0.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$7.02 - $13.08 $642,330 - $1.2 Million	-91,500 Reduced 66.98%	45,102 $325,000
Q2 2024 Jul 25, 2024	BUY	$10.58 - $17.9 $285,660 - $483,299	27,000 Added 24.63%	136,602 $1.48 Million
Q1 2024 May 03, 2024	SELL	$18.62 - $26.95 $242,823 - $351,454	-13,041 Reduced 10.63%	109,602 $2.05 Million
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $1.25 Million - $1.62 Million	-73,000 Reduced 37.31%	122,643 $2.66 Million
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $2.42 Million - $7.08 Million	144,522 Added 282.71%	195,643 $4.03 Million
Q2 2023 Nov 13, 2023	SELL	$40.65 - $59.54 $1.2 Million - $1.76 Million	-29,524 Reduced 36.61%	51,121 $2.4 Million
Q1 2023 Nov 13, 2023	BUY	$37.27 - $46.57 $74,540 - $93,140	2,000 Added 2.54%	80,645 $3.38 Million
Q1 2023 May 02, 2023	BUY	$37.27 - $46.57 $85,273 - $106,552	2,288 Added 2.91%	80,789 $3.39 Million
Q4 2022 Nov 13, 2023	SELL	$32.2 - $43.61 $69,036 - $93,499	-2,144 Reduced 2.65%	78,645 $3 Million
Q4 2022 Feb 10, 2023	BUY	$32.2 - $43.61 $477,719 - $646,997	14,836 Added 23.3%	78,501 $2.99 Million
Q3 2022 Nov 09, 2022	SELL	$32.28 - $43.27 $80,700 - $108,175	-2,500 Reduced 3.78%	63,665 $2.49 Million
Q2 2022 Aug 10, 2022	BUY	$27.52 - $37.99 $895,913 - $1.24 Million	32,555 Added 96.86%	66,165 $2.14 Million
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $1.03 Million - $1.54 Million	33,610 New	33,610 $1.11 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $342M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Easterly Investment Partners LLC with notifications on news.

Account

Easterly Investment Partners LLC Sage Therapeutics, Inc. Transaction History